Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555312 |
US |
2 | |
Myocardial infarction, Diabetes mellitus, Blood glucose increased, Nasopharyngitis, Throat irritation, Cough, Headache, Visual impairment, |
||||
INCLISIRAN, |
||||
| 2 | 26555430 |
JP |
8 | 1 |
Glycosylated haemoglobin increased, Blood glucose increased, Orthopaedic procedure, |
||||
ACARBOSE, CANAGLIFLOZIN, GLIMEPIRIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, PIOGLITAZONE HYDROCHLORIDE, ORAL SEMAGLUTIDE, |
||||
| 3 | 26555671 |
US |
63 | 1 |
Large intestinal stenosis, Colitis, Middle ear effusion, Feeling abnormal, Gastrointestinal disorder, Inflammation, Frustration tolerance decreased, Memory impairment, Blood glucose increased, Abdominal distension, Nausea, Diarrhoea, Constipation, |
||||
TIRZEPATIDE, TENAPANOR HYDROCHLORIDE, TENAPANOR HYDROCHLORIDE, PLECANATIDE, |
||||
| 4 | 26555891 |
US |
1 | |
Malaise, Asthenia, Dizziness, Contusion, Irritability, Blood glucose increased, Memory impairment, Fear, |
||||
RAVULIZUMAB, PREDNISONE, PYRIDOSTIGMINE BROMIDE, |
||||
| 5 | 26556029 |
US |
||
Blood glucose increased, Constipation, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, INSULIN LISPRO, LISINOPRIL, EZETIMIBE, |
||||
| 6 | 26557569 |
US |
75 | 2 |
Bronchitis, Dyspnoea, Blood glucose increased, Off label use, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 7 | 26557845 |
CA |
54 | 2 |
Neuropathy peripheral, Weight decreased, Headache, Chest pain, Pericardial effusion, Blood glucose increased, Thyroid disorder, Eye haemorrhage, Multi-organ disorder, Myalgia, Abdominal pain upper, Cardiac failure congestive, Pulmonary oedema, Arthritis, Malnutrition, Diarrhoea, |
||||
ESOMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, INSULIN HUMAN, INSULIN GLARGINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, INSULIN LISPRO, INSULIN GLARGINE, INSULIN GLARGINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, LOSARTAN, LOSARTAN, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SALMETEROL XINAFOATE, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, |
||||
| 8 | 26557966 |
US |
72 | 2 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 9 | 26558412 |
US |
67 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 10 | 26559177 |
US |
||
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 11 | 26559429 |
CN |
88 | 1 |
Renal impairment, Chronic hepatitis B, Peripheral swelling, Joint swelling, Blood glucose increased, Drug effect less than expected, |
||||
HUMAN INSULIN, HUMAN INSULIN, HUMAN INSULIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 12 | 26559436 |
US |
73 | |
Decreased appetite, Chills, Diarrhoea, Gastrointestinal disorder, Dehydration, Blood glucose increased, Fatigue, Asthenia, |
||||
FECAL MICROBIOTA SPORES, LIVE-BRPK, FECAL MICROBIOTA SPORES, LIVE-BRPK, |
||||
| 13 | 26559530 |
US |
59 | 1 |
Blood glucose increased, Weight decreased, Blood pressure increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 14 | 26560144 |
US |
73 | |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 15 | 26560804 |
US |
67 | 1 |
Expired product administered, Blood glucose increased, Product storage error, Wrong product administered, |
||||
INSULIN GLARGINE, INSULIN LISPRO, INSULIN GLARGINE, EMPAGLIFLOZIN, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 16 | 26560977 |
US |
2 | |
Blood pressure increased, Blood glucose increased, Intentional product use issue, Intentional product misuse, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TIRZEPATIDE, MELOXICAM, |
||||
| 17 | 26561335 |
BR |
42 | 1 |
Blood glucose increased, Off label use, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 18 | 26561474 |
US |
66 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 19 | 26569892 |
2 | ||
Blood glucose increased, Dry mouth, Fatigue, Decreased appetite, Vomiting, Nausea, Vision blurred, Diarrhoea, Therapy interrupted, |
||||
FULVESTRANT, CAPIVASERTIB, |
||||
| 20 | 26571041 |
89 | 1 | |
Blood glucose increased, Dementia, Gait disturbance, |
||||
PIRTOBRUTINIB, |
||||
| 21 | 26550015 |
US |
63 | 1 |
Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, |
||||
| 22 | 26550081 |
US |
83 | 1 |
Blood glucose increased, Product dispensing issue, |
||||
INSULIN GLARGINE, |
||||
| 23 | 26550238 |
US |
72 | 2 |
Blood glucose increased, Drug dose omission by device, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 24 | 26550709 |
CA |
43 | 1 |
Arthralgia, Blood glucose increased, Cellulitis, Headache, Hypersensitivity, Injection site pain, Joint dislocation, Psoriasis, Therapy interrupted, Drug ineffective, Product distribution issue, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BRODALUMAB, BRODALUMAB, BRODALUMAB, |
||||
| 25 | 26551394 |
US |
31 | 1 |
Blood glucose increased, Product use in unapproved indication, |
||||
BELUMOSUDIL, ACYCLOVIR, FAMOTIDINE, HYDROXYZINE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PREDNISONE, LETERMOVIR, ELTROMBOPAG OLAMINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, URSODIOL, URSOSIOL, |
||||
| 26 | 26551656 |
US |
51 | 1 |
Blood glucose increased, Thirst, Product dose omission issue, |
||||
SITAGLIPTIN, GLIPIZIDE, GLIPIZIDE-TABLETS, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 27 | 26551707 |
US |
30 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, |
||||
| 28 | 26552767 |
US |
76 | 1 |
Dizziness, Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 29 | 26552793 |
JP |
1 | |
Urine albumin/creatinine ratio increased, Blood glucose increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, GLIMEPIRIDE, GLIMEPIRIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FINERENONE, FINERENONE, |
||||
| 30 | 26553680 |
2 | ||
Flushing, Blood glucose increased, |
||||
| 31 | 26553684 |
72 | 2 | |
Flushing, Blood glucose increased, |
||||
| 32 | 26553686 |
2 | ||
Blood glucose increased, |
||||
SARILUMAB, |
||||
| 33 | 26554407 |
54 | 2 | |
Arthritis, Blood glucose increased, Cardiac failure congestive, Eye haemorrhage, Malnutrition, Multi-organ disorder, Neuropathy peripheral, Pericardial effusion, Pulmonary oedema, Thyroid disorder, Weight decreased, Headache, Myalgia, Chest pain, Abdominal pain upper, Diarrhoea, |
||||
LOSARTAN, LOSARTAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, INSULIN LISPRO, INSULIN HUMAN, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SALMETEROL XINAFOATE, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, |
||||
| 34 | 26554444 |
2 | ||
Blood glucose increased, Swelling, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS, SERTRALINE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 35 | 26554461 |
CH |
60 | 1 |
Pulmonary embolism, Prostatomegaly, Calculus bladder, Haematuria, Haemorrhage, Blood glucose increased, Glycosylated haemoglobin increased, Nephrolithiasis, Balanitis candida, |
||||
DULAGLUTIDE, INSULIN DEGLUDEC, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EPLERENONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ZOLPIDEM TARTRATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, |
||||
| 36 | 26554520 |
US |
||
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 37 | 26554982 |
US |
||
Blood glucose increased, |
||||
INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 38 | 26555004 |
1 | ||
Blood glucose increased, |
||||
| 39 | 26555024 |
US |
1 | |
Dementia Alzheimer^s type, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 40 | 26558218 |
68 | 2 | |
Weight increased, Hepatic steatosis, Blood glucose increased, Hypertension, Neuropathy peripheral, Arthralgia, Cough, Therapy interrupted, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 41 | 26549088 |
US |
11 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 42 | 26549499 |
US |
76 | 1 |
Blood glucose increased, |
||||
DUPILUMAB, |
||||
| 43 | 26549739 |
US |
84 | 2 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 44 | 26549750 |
US |
78 | 1 |
Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO, DULAGLUTIDE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 45 | 26549934 |
US |
66 | 1 |
Metastases to lymph nodes, Tumour lysis syndrome, Colitis, Sluggishness, Lymphocyte count decreased, Blood chloride abnormal, Memory impairment, Blood urea abnormal, Blood bilirubin abnormal, Beta 2 microglobulin increased, Prostatic specific antigen increased, Drug intolerance, Contusion, White blood cell count abnormal, Malaise, Decreased appetite, Pain, Cough, Hypoaesthesia, Abdominal pain, Headache, Blood glucose increased, Hyperhidrosis, Fatigue, Off label use, |
||||
LEUPROLIDE, RELUGOLIX, POMALIDOMIDE, ACYCLOVIR, IXAZOMIB, BICALUTAMIDE, DARATUMUMAB, METHADONE, OXYCODONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, RELUGOLIX, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, RELUGOLIX, RELUGOLIX, LEUPROLIDE, LEUPROLIDE, LEUPROLIDE, ACYCLOVIR, IXAZOMIB, IXAZOMIB, |
||||
| 46 | 26547614 |
US |
79 | 2 |
Blood glucose increased, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 47 | 26548100 |
US |
73 | 2 |
Blood glucose increased, |
||||
SARILUMAB, PREDNISONE, |
||||
| 48 | 26548381 |
US |
2 | |
Blood glucose increased, Seasonal allergy, |
||||
TREPROSTINIL, TREPROSTINIL, PREDNISONE, ERGOCALCIFEROL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, GABAPENTIN, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BIOTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SIMVASTATIN, OXYGEN, 0XYGEN, TORSEMIDE, |
||||
| 49 | 26548525 |
54 | 2 | |
Arthritis, Blood glucose increased, Cardiac failure congestive, Eye haemorrhage, Malnutrition, Multi-organ disorder, Neuropathy peripheral, Pericardial effusion, Pulmonary oedema, Thyroid disorder, Weight decreased, Abdominal pain upper, Chest pain, Diarrhoea, Headache, Myalgia, |
||||
LOSARTAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, INSULIN LISPRO, INSULIN HUMAN, INSULIN GLARGINE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SALMETEROL XINAFOATE, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, |
||||
| 50 | 26548665 |
US |
47 | 1 |
Blood glucose increased, Intentional product misuse, Device defective, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 51 | 26548700 |
US |
85 | 1 |
Blood glucose increased, Drug ineffective, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 52 | 26548745 |
US |
93 | 1 |
Blood glucose increased, Multiple use of single-use product, |
||||
INSULIN GLARGINE, |
||||
| 53 | 26548786 |
US |
||
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 54 | 26548811 |
US |
76 | 1 |
Blood glucose increased, Product use issue, |
||||
RELUGOLIX, |
||||
| 55 | 26542467 |
US |
1 | |
Blood glucose increased, Glycosylated haemoglobin increased, |
||||
INSULIN LISPRO, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 56 | 26542723 |
US |
66 | 2 |
Blood glucose increased, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 57 | 26543045 |
US |
64 | 1 |
Hyperhidrosis, Dizziness, Presyncope, Blood glucose increased, Weight increased, Drug ineffective, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 58 | 26543052 |
US |
79 | 1 |
Blood glucose increased, Product complaint, Drug ineffective, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 59 | 26543121 |
55 | ||
Blood glucose increased, Blood pressure increased, Oxygen saturation decreased, Heart rate increased, |
||||
OLEZARSEN SODIUM, LISINOPRIL, |
||||
| 60 | 26543883 |
US |
76 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 61 | 26543981 |
CL |
46 | 2 |
Metastases to lung, Azotaemia, Leukopenia, Pulmonary mass, Chest pain, Hilar lymphadenopathy, Lymphadenopathy mediastinal, Hepatic steatosis, Red cell distribution width increased, Anisocytosis, Reticulocyte percentage increased, Red blood cell sedimentation rate increased, Tri-iodothyronine free increased, Blood cholesterol increased, Blood phosphorus increased, Aspartate aminotransferase decreased, Glucose urine present, Bacterial test positive, Urine abnormality, Urinary sediment present, Neutrophil toxic granulation present, Eosinophil percentage increased, Tri-iodothyronine free increased, Crystal urine present, Blood thyroid stimulating hormone increased, Blood lactate dehydrogenase increased, Blood urea increased, Blood phosphorus increased, Aspartate aminotransferase increased, Gastrooesophageal reflux disease, Hypertension, Fatigue, Diarrhoea, Blood glucose increased, Depression, Aspartate aminotransferase increased, |
||||
ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, FULVESTRANT, LINAGLIPTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 62 | 26544380 |
55 | 1 | |
Blood glucose increased, Dehydration, |
||||
INSULIN LISPRO, |
||||
| 63 | 26544381 |
2 | 2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 64 | 26544516 |
US |
1 | |
Blood glucose increased, Constipation, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 65 | 26544879 |
66 | ||
Aspartate aminotransferase increased, Alanine aminotransferase increased, Blood bilirubin increased, Blood glucose increased, Product use in unapproved indication, |
||||
RESMETIROM, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 66 | 26544883 |
66 | ||
Feeling abnormal, Pain, Arthralgia, Hot flush, Cold flash, Blood glucose increased, Abdominal discomfort, Abdominal pain upper, |
||||
RESMETIROM, ROSUVASTATIN CALCIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, AMITRIPTYLINE HYDROCHLORIDE, ALPRAZOLAM, CAPSAICIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, BRIMONIDINE TARTRATE, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, LATANOPROST, |
||||
| 67 | 26544901 |
US |
82 | 2 |
Blood glucose increased, Incorrect dose administered by device, Device mechanical issue, Device malfunction, Product quality issue, |
||||
LIRAGLUTIDE, |
||||
| 68 | 26544997 |
US |
70 | 2 |
Mobility decreased, Blood glucose increased, Muscle atrophy, Illness, Weight decreased, Myalgia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 69 | 26545127 |
CA |
||
Blood glucose increased, Blood prolactin increased, Cortisol increased, Dehydration, Diabetes mellitus, Feeling abnormal, White blood cell count decreased, Weight increased, Constipation, |
||||
OLANZAPINE, |
||||
| 70 | 26545520 |
US |
64 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 71 | 26546051 |
58 | 2 | |
Anaphylactic shock, Altered state of consciousness, Unresponsive to stimuli, Coma, Respiratory arrest, Cardiac arrest, Acid base balance abnormal, Anal incontinence, Urinary incontinence, Hypoxic-ischaemic encephalopathy, Brain oedema, Electrocardiogram ST segment depression, Seizure, Sinus tachycardia, Pyrexia, Hypoproteinaemia, Blood glucose increased, Blood pressure fluctuation, Flushing, Blood urea increased, Gamma-glutamyltransferase increased, Aspartate aminotransferase increased, AST/ALT ratio increased, Haemoglobin increased, |
||||
IOPROMIDE, IOPROMIDE, |
||||
| 72 | 26546701 |
TR |
2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 73 | 26552017 |
2 | ||
Weight decreased, Decreased appetite, Blood glucose increased, |
||||
ALPELISIB, |
||||
| 74 | 26554420 |
54 | 2 | |
Thirst, Hunger, Weight increased, Loss of consciousness, Road traffic accident, Blood glucose increased, Glycosylated haemoglobin increased, Drug ineffective, Loss of employment, Activities of daily living decreased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, TIRZEPATIDE, EMPAGLIFLOZIN, |
||||
| 75 | 26536641 |
EU |
4 | 2 |
Blood glucose increased, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 76 | 26537203 |
US |
71 | 2 |
Diabetic ketoacidosis, Blood creatinine increased, Blood glucose increased, |
||||
DOSTARLIMAB, DOSTARLIMAB, |
||||
| 77 | 26537331 |
US |
51 | 2 |
Blood glucose increased, Glycosylated haemoglobin increased, Nausea, Vomiting, |
||||
INSULIN GLARGINE, LIRAGLUTIDE, |
||||
| 78 | 26537840 |
US |
2 | |
Illness, Blood glucose increased, Intentional product misuse, |
||||
INSULIN GLARGINE, PREDNISONE, |
||||
| 79 | 26537888 |
US |
67 | 2 |
Malaise, Blood glucose increased, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 80 | 26538065 |
EG |
2 | |
Blood glucose increased, Rash, Erythema, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 81 | 26538126 |
US |
2 | |
Affect lability, Depression, Diabetes mellitus inadequate control, Peripheral swelling, Blood glucose increased, |
||||
INSULIN ASPART, |
||||
| 82 | 26538179 |
US |
2 | |
Blood glucose increased, Device use issue, |
||||
INSULIN GLARGINE, |
||||
| 83 | 26538397 |
US |
10 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 84 | 26538403 |
71 | ||
Laboratory test abnormal, Blood glucose increased, Blood cholesterol increased, |
||||
TIRZEPATIDE, |
||||
| 85 | 26538407 |
US |
68 | 1 |
Malignant neoplasm progression, Neuropathy peripheral, Vocal cord paralysis, Haemoptysis, General physical condition abnormal, White blood cell count increased, Decreased appetite, Blood alkaline phosphatase increased, Blood sodium decreased, Blood chloride decreased, Fatigue, Dysphonia, Cough, Arthralgia, Myalgia, Weight decreased, Haemoglobin decreased, Haematocrit decreased, Blood glucose increased, Seborrhoeic dermatitis, Pruritus, Normocytic anaemia, Hypertension, Oedema, Off label use, Drug intolerance, Oedema peripheral, Erythema, Confusional state, Dysphonia, Respiratory disorder, Gastrooesophageal reflux disease, Nausea, Vomiting, Hypoglycaemia, Visual impairment, Dyspnoea, Dyspnoea, |
||||
OLAPARIB, OLAPARIB, NICOTINE POLACRILEX, |
||||
| 86 | 26538713 |
ZA |
82 | 2 |
Malaise, Catheter site haemorrhage, Bladder catheterisation, Blood glucose increased, Device leakage, Off label use, Incorrect dose administered, Wrong product administered, |
||||
INSULIN GLULISINE, INSULIN GLULISINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 87 | 26538890 |
US |
66 | 1 |
Metastases to lymph nodes, Tumour lysis syndrome, Colitis, Sluggishness, Lymphocyte count decreased, Blood chloride abnormal, Memory impairment, Blood urea abnormal, Blood bilirubin abnormal, Beta 2 microglobulin increased, Prostatic specific antigen increased, Drug intolerance, Contusion, White blood cell count abnormal, Malaise, Decreased appetite, Pain, Cough, Hypoaesthesia, Abdominal pain, Headache, Blood glucose increased, Hyperhidrosis, Fatigue, Off label use, |
||||
RELUGOLIX, RELUGOLIX, RELUGOLIX, RELUGOLIX, ACYCLOVIR, ACYCLOVIR, BICALUTAMIDE, LEUPROLIDE, LEUPROLIDE, LEUPROLIDE, IXAZOMIB, IXAZOMIB, IXAZOMIB, DARATUMUMAB, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, METHADONE, OXYCODONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, |
||||
| 88 | 26539313 |
US |
68 | 2 |
Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, |
||||
| 89 | 26539438 |
US |
2 | |
Blood glucose increased, Oedema peripheral, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, |
||||
| 90 | 26539912 |
US |
81 | 2 |
Blood glucose increased, Drug dose omission by device, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 91 | 26540540 |
US |
92 | 2 |
Blood glucose increased, Lacrimation increased, Rhinorrhoea, Eye irritation, |
||||
ACOLTREMON, GLIPIZIDE, GLIPIZIDE-TABLETS, SITAGLIPTIN, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 92 | 26541245 |
US |
41 | 1 |
Diabetic ketoacidosis, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, INSULIN ASPART, |
||||
| 93 | 26541273 |
US |
42 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 94 | 26541792 |
US |
1 | |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 95 | 26541793 |
US |
78 | 2 |
Incorrect product administration duration, Wrong technique in product usage process, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 96 | 26541847 |
US |
37 | 2 |
Type 1 diabetes mellitus, Blood glucose increased, Systemic lupus erythematosus, Neck pain, Arthralgia, Pain in extremity, Pain, |
||||
| 97 | 26541897 |
CA |
83 | 2 |
Anion gap increased, Blood glucose increased, Hyperglycaemia, Right ventricular dilatation, Shock, Fatigue, Dyspnoea, |
||||
FULVESTRANT, CAPIVASERTIB, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, APIXABAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, |
||||
| 98 | 26543685 |
62 | 1 | |
Blood glucose increased, |
||||
MAVACAMTEN, |
||||
| 99 | 26543910 |
1 | ||
Blood glucose increased, Cerebrovascular accident, |
||||
SIROLIMUS, INSULIN GLARGINE, PREDNISONE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, FLUCONAZOLE, FUROSEMIDE, GLIPIZIDE, GLIPIZIDE-TABLETS, HYDRALAZINE HYDROCHLORIDE, SITAGLIPTIN, LEFLUNOMIDE, |
||||
| 100 | 26531295 |
US |
60 | 1 |
Milk-alkali syndrome, Mental status changes, Disorientation, Fatigue, Hypercalcaemia, Metabolic alkalosis, Acute kidney injury, Hypovolaemia, Dehydration, Dysarthria, Vitamin D deficiency, Blood 25-hydroxycholecalciferol decreased, Blood calcium increased, Blood chloride decreased, Blood creatinine increased, Blood glucose increased, Blood sodium decreased, Blood thyroid stimulating hormone decreased, Blood urea increased, Electrocardiogram QT prolonged, Heart rate increased, Overdose, |
||||
CALCIUM CARBONATE, ANTACID, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, METOPROLOL TARTRATE, METOPROLOL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28